An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire Medical Systems (NYSE:INSP) shares rose slightly after hours today on fourth-quarter results that beat the consensus ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...

Since iOS 18 was released in September 2024, Apple has introduced an unprecedented number of new features and improvements ...

The price is higher than Oura, but Samsung lets you trade in devices to bring the price down. Our take: The Fitbit Inspire 3 is ... the Apple Watch detect sleep apnea? Supported models such ...

Learn more about whether ICU Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...

Omnicell (OMCL) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.33 per share a year ago. These figures are ...

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...